Help | RSS Feed



Aviragen Therapeutics, Inc. (NASD:AVIR) Seasonal Chart

Aviragen Therapeutics, Inc. (NASD:AVIR) Seasonality

AVIR Relative to the S&P 500
AVIR Relative to the S&P 500

AVIR Relative to the Sector
AVIR Relative to the Sector

Monthly Seasonal Aviragen Therapeutics, Inc. (NASD:AVIR)

Seasonal Chart Analysis

Analysis of the Aviragen Therapeutics, Inc. (NASD:AVIR) seasonal charts above shows that a Buy Date of June 7 and a Sell Date of September 21 has resulted in a geometric average return of 2.5% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 20.68% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore